DICE THERAPEUTICS INC's ticker is and the CUSIP is 23345J104. A total of 111 filers reported holding DICE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 11.16 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $16,087,286 | +81.7% | 346,261 | +12.1% | 0.00% | +50.0% |
| Q1 2023 | $8,852,765 | -8.2% | 308,997 | -0.0% | 0.00% | 0.0% |
| Q4 2022 | $9,645,073 | +106.4% | 309,137 | +34.1% | 0.00% | +100.0% |
| Q3 2022 | $4,674,000 | +41.3% | 230,480 | +8.1% | 0.00% | 0.0% |
| Q2 2022 | $3,307,000 | +45.0% | 213,113 | +78.8% | 0.00% | – |
| Q1 2022 | $2,281,000 | -27.8% | 119,220 | -4.4% | 0.00% | -100.0% |
| Q4 2021 | $3,158,000 | – | 124,768 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Northpond Ventures, LLC | 3,292,871 | $62,993,000 | 33.95% |
| Sands Capital Ventures, LLC | 3,148,970 | $60,240,000 | 12.58% |
| OUP Management Co., LLC | 536,693 | $10,267,000 | 7.82% |
| New Leaf Venture Partners, L.L.C. | 556,693 | $10,650,000 | 5.25% |
| Logos Global Management LP | 1,385,251 | $26,500,000 | 3.44% |
| Soleus Capital Management, L.P. | 983,994 | $18,824,000 | 2.43% |
| RA Capital Management | 5,208,911 | $99,646,000 | 2.17% |
| Deep Track Capital, LP | 1,250,000 | $23,913,000 | 1.53% |
| Samsara BioCapital, LLC | 228,466 | $4,371,000 | 1.10% |
| HighVista Strategies LLC | 48,960 | $937,000 | 0.60% |